Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Invion ( (AU:IVX) ) has shared an update.
Invion Limited has announced a fully underwritten pro-rata non-renounceable offer of Loyalty Options to eligible shareholders, managed by Blue Ocean Equities Pty Ltd. The offer allows shareholders to subscribe for 77 Loyalty Options for every 100 shares held, with an exercise price of $0.14, expiring on 30 June 2027. This initiative, supported by Invion’s Executive Chairman and CEO, Prof Thian Chew, aims to strengthen the company’s financial position and enhance shareholder value.
More about Invion
Invion Limited is a company in the biotechnology sector, focusing on developing treatments and technologies for health-related applications. The company is listed on the Australian Securities Exchange (ASX) under the ticker IVX.
YTD Price Performance: -55.36%
Average Trading Volume: 101,227
Technical Sentiment Signal: Sell
Current Market Cap: A$10.59M
See more data about IVX stock on TipRanks’ Stock Analysis page.